Brief: Kubota Pharmaceutical Holdings unit signs option contract with EyeMedics to get exclusive license for manufacturing, development and sale of new biomimetic technology
Dec 14 (Reuters) - Kubota Pharmaceutical Holdings 4596.T :
* Says its wholly owned subsidiary Acucela Inc. signed a
option contract with EyeMedics to get exclusive license for
manufacturing, development and sale of a new biomimetic
technology on Dec. 14
Source text in Japanese: https://goo.gl/1Ft63l
Further company coverage: 4596.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com;)(+86 010
62674724;)(Reuters
Messaging:)(shuai.liu.reuters.com@reuters.net))
Recent news on Kubota Pharmaceutical Holdings
See all newsTable: Kubota Pharmaceutical Holdings 6-MTH group results (IFRS)
Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)
Brief: Kubota Vision Signs Supply & Licensing Agreement With Laboratoires Kôl
Table: Kubota Pharmaceutical Holdings -2025 parent results
Table: Kubota Pharmaceutical Holdings -2025 group results (IFRS)